At #GDULC , Koosha Paydary, MD, MPH, MSc, argued that CTLA-4 inhibitors should not be used to treat patients with PD-L1 negative or PD-L1 <1% lung cancers. Learn more: hmpgloballearningnetwork.com/site/onc/confe…

#medtwitter #onctwitter

The Case Against Perioperative Immunotherapy in Lung Cancer Treatment hmpgloballearningnetwork.com/site/onc/confe…
Christian Rolfo Icahn School of Medicine at Mount Sinai #lungcancer

The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai Thanks Great Debates & Updates for the interview on the debate we had with Jamie Chaft recently. As all debates we need to make the pro or con side but the important of the discussion is to have opportunities for our patients in early stage disease with peroperative approaches.

At #GDUWO , Bradley Monk, MD, discussed whether PARP inhibitors are the optimal maintenance therapy for patients with advanced epithelial ovarian cancer. Learn more: hmpgloballearningnetwork.com/site/onc/confe…

#medtwitter #onctwitter

Fun day debating topics in breast cancer at Great Debates & Updates in Women’s Oncology in NYC. Enjoyed learning from brilliant colleagues and seeing industry friends. Thanks to organizers and to Erika Hamilton, MD for her amazing job chairing!
#GDUWO #greatdebatesandupdates

Up next: Discover the pivotal role of KISQALI in the HR+/HER2 - mBC landscape with Karthik Kumaravel, sponsored by Novartis Cancer. Join us in Belasco!

Welcome to Day 2 of Great Debates & Updates in Women's Oncology! Sessions begin at 9:00 a.m. ET. We can't wait to see you there.
#GDUWO #greatdebatesandupdates

Paolo Tarantino Erica Mayer Dana-Farber’s Breast Oncology Center Great Debates & Updates Insightful on ER+ breast cancer & age Paolo Tarantino. Emphasizes personalized medicine in healthcare policy. Erica Mayer's wisdom is crucial.

Does Age 50 Really Matter THAT Much for decision making in early ER+ breast cancer? Erica Mayer (Erica Mayer) from Dana-Farber’s Breast Oncology Center supports the argument of YES, age matters! Great Debates & Updates

Continue the day with something sweet ➡ Enjoy dessert with Dr. Anne O'Dea at 3:15 p.m. as she explores the path forward with ORSERDU for patients with an ESR1 mutation. Sponsored by Menarini Stemline. Don't miss out on this enlightening session!
#GDUWO #greatdebatesandupdates

Join us for a transformative lunch session at our Innovation Theater in Belasco! 🍽️ Explore Expanded Horizons with Dr. Martin Dietrich as he delves into groundbreaking treatments for HR+/HER2- mBC and mTNBC. Sponsored by Gilead Oncology.
#GDUWO #greatdebatesandupdates

Up next: Join us for breakfast during our Innovation Theater led by Sramila Aithal, MD sponsored by Pfizer Oncology Medical, happening in Belasco. #GDUWO #greatdebatesandupdates

Welcome to Day 1 of Great Debates & Updates in Women's Oncology! Sessions begin at 8:30 a.m. ET. First things first. Pick up your badge at the Registration Desk on on the 3rd Floor in the Broadway Ballroom Foyer and get:
✔ A 30-day on-demand package replay on us
✔ A caffeine…

Should be a great event with free registration for clinicians! Great Debates & Updates

Are you ready to embrace the latest advances and controversial topics in the field of breast and gynecological cancers? Claim your free registration today ➡️hmpglobalevents.com/gduwo/rates

Already registered? Share the graphic below ⬇️

The timing couldn’t be more appropriate for this upcoming debate with Claudine Isaacs.

HER2-low: should we even test?

hmpglobalevents.com/gduwo?amp Great Debates & Updates Erika Hamilton, MD

At #GDULC Jamie Chaft, MD, argued in favor of perioperative immunotherapy in the treatment of lung cancer. Learn more: hmpgloballearningnetwork.com/site/onc/confe…

#medtwitter #onctwitter

Are you registered for Great Debates & Updates in Women's Oncology this week? Join us at the Westin Times Square on May 3-4 and get ready to elevate patient care! Register now ➡ hmpglobalevents.com/gduwo/rates
#gduwo #greatdebatesandupdates

At #GDULC Charles Simone, MD, argued that surgical approaches have a limited role in the treatment of patients with stage 3 NSCLC. Learn more: hmpgloballearningnetwork.com/site/onc/confe…

#medtwitter #onctwitter

Don't miss out on today's highlighted sessions including one debate featuring our #GDULC chairs, Corey Langer, MD, FACP and Edward Garon, MD, MS!
#greatdebatesandupdates